Early‐stage vaginal carcinoma – an analysis of 70 patients

Early‐stage vaginal carcinoma – an analysis of 70 patients

. Objectives:  The aims of this study were to assess outcomes and define prognostic factors for early‐stage vaginal carcinoma. Methods:  A retrospective analysis was performed of women with FIGO stages I and II vaginal carcinoma identified from the database of the Queensland Centre for Gynaecologica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of gynecological cancer 2004-03, Vol.14 (2), p.304-310
Hauptverfasser: Otton, G. R., Nicklin, J. L., Dickie, G. J., Niedetzky, P., Tripcony, L., Perrin, L. C., Crandon, A. J.
Format: Artikel
Sprache:eng
Schlagworte:
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Adenocarcinoma - radiotherapy
Adenocarcinoma - surgery
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - radiotherapy
Carcinoma, Squamous Cell - surgery
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Medical Records
Middle Aged
Neoplasm Recurrence, Local - mortality
Neoplasm Recurrence, Local - pathology
Neoplasm Recurrence, Local - radiotherapy
Neoplasm Recurrence, Local - surgery
Neoplasm Staging
prognostic factors
Queensland - epidemiology
Retrospective Studies
survival
Survival Analysis
vaginal carcinoma
Vaginal Neoplasms - mortality
Vaginal Neoplasms - pathology
Vaginal Neoplasms - radiotherapy
Vaginal Neoplasms - surgery
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:. Objectives:  The aims of this study were to assess outcomes and define prognostic factors for early‐stage vaginal carcinoma. Methods:  A retrospective analysis was performed of women with FIGO stages I and II vaginal carcinoma identified from the database of the Queensland Centre for Gynaecological Cancer between January 1982 and December 1998. Results:  Seventy women were identified. The 5‐year survivals for stages I and II carcinomas were 71 and 48%, respectively (P 
ISSN:1048-891X
1525-1438
DOI:10.1111/j.1048-891X.2004.014214.x